Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Baker

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolismR M Franke, C S Lancaster, C J Peer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancerS D Baker, M Wirth, P Statkevich, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinibV Gregorc, M Hidalgo, A Spreafico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxelM O Bradley, N L Webb, F H Anthony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077C D Britten, E K Rowinsky, S D Baker, et al.
Journal of Animal Science|March 18, 2006
Residual feed intake of purebred Angus steers: effects on meat quality and palatabilityS D Baker, J I Szasz, T A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracilS D Baker, R B Diasio, S O'Reilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignanciesL A Hammond, J R Eckardt, S D Baker, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolismR M Franke, C S Lancaster, C J Peer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancerS D Baker, M Wirth, P Statkevich, et al.
Clinical Pharmacology and Therapeutics|August 24, 2007
Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinibV Gregorc, M Hidalgo, A Spreafico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxelM O Bradley, N L Webb, F H Anthony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077C D Britten, E K Rowinsky, S D Baker, et al.
Journal of Animal Science|March 18, 2006
Residual feed intake of purebred Angus steers: effects on meat quality and palatabilityS D Baker, J I Szasz, T A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracilS D Baker, R B Diasio, S O'Reilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignanciesL A Hammond, J R Eckardt, S D Baker, et al.
Pageof 7